Wallemacq P - Search Results

1

Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.

Musuamba FT, Mourad M, Haufroid V, De Meyer M, Capron A, Delattre IK, Verbeeck RK, Wallemacq P. Musuamba FT, et al. Among authors: wallemacq p. Br J Clin Pharmacol. 2013 May;75(5):1277-88. doi: 10.1111/bcp.12007. Br J Clin Pharmacol. 2013. PMID: 23072565 Free PMC article.

2

Isolation and mass spectrometric identification of five metabolites of FK-506, a novel macrolide immunosuppressive agent, from human plasma.

Lhoëst G, Wallemacq P, Verbeeck R. Lhoëst G, et al. Among authors: wallemacq p. Pharm Acta Helv. 1991;66(11):302-6. Pharm Acta Helv. 1991. PMID: 1722046 No abstract available.

3

HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients.

Firdaous I, Hassoun A, Otte JB, Reding R, Squifflet JP, Besse T, Wallemacq PE. Firdaous I, et al. Among authors: wallemacq pe. Clin Chem. 1995 Sep;41(9):1292-6. Clin Chem. 1995. PMID: 7544705

4

FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

Wallemacq PE, Reding R. Wallemacq PE, et al. Clin Chem. 1993 Nov;39(11 Pt 1):2219-28. Clin Chem. 1993. PMID: 7693372 Free PMC article. Review.

5

The interaction between clarithromycin and cyclosporine in kidney transplant recipients.

Ferrari SL, Goffin E, Mourad M, Wallemacq P, Squifflet JP, Pirson Y. Ferrari SL, et al. Among authors: wallemacq p. Transplantation. 1994 Sep 27;58(6):725-7. Transplantation. 1994. PMID: 7940695 No abstract available.

6

Excretion of tacrolimus glucuronides in human bile.

Firdaous I, Verbeeck RK, Hassoun A, Langrehr JM, Wallemacq PE. Firdaous I, et al. Among authors: wallemacq pe. Eur J Drug Metab Pharmacokinet. 1997 Jul-Sep;22(3):217-21. doi: 10.1007/BF03189810. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9358202

7

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

Wallemacq PE, Furlan V, Möller A, Schäfer A, Stadler P, Firdaous I, Taburet AM, Reding R, Clement De Clety S, De Ville De Goyet J, Sokal E, Lykavieris L, Van Leeuw V, Bernard O, Otte JB, Undre NA. Wallemacq PE, et al. Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep;23(3):367-70. doi: 10.1007/BF03192295. Eur J Drug Metab Pharmacokinet. 1998. PMID: 9842978 Clinical Trial.

8

Isolation from pig liver microsomes, identification by electrospray tandem mass spectrometry and in vitro immunosuppressive activity of a rapamycin tris-epoxide metabolite.

Lhoëst G, Zey T, Verbeeck RK, Wallemacq P, Maton N, De Houx JP, Latinne D. Lhoëst G, et al. Among authors: wallemacq p. J Mass Spectrom. 1999 Jan;34(1):28-32. doi: 10.1002/(SICI)1096-9888(199901)34:1<28::AID-JMS747>3.0.CO;2-#. J Mass Spectrom. 1999. PMID: 10028689

9

Two cases of acute methanol poisoning partially treated by oral 4-methylpyrazole.

Hantson P, Wallemacq P, Brau M, Vanbinst R, Haufroid V, Mahieu P. Hantson P, et al. Among authors: wallemacq p. Intensive Care Med. 1999 May;25(5):528-31. doi: 10.1007/s001340050893. Intensive Care Med. 1999. PMID: 10401951

10

Isolation, identification and immunosuppressive activity of SDZ-IMM-125 metabolites from human liver microsomes.

Dieden R, Verbeeck RK, Latinne D, Wallemacq P, Maton N, Lhoest GJ. Dieden R, et al. Among authors: wallemacq p. Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):83-90. doi: 10.1007/BF03190015. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10412896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters